EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 25 September 2025

News

Alzheimer’s disease: future-proofing the healthcare journey in Europe
25 September 2025

A new EFPIA report highlights emerging best practices as novel therapies, biomarkers and digital innovations offer fresh... Read more

Siloed thinking on cancer innovation puts future care at risk, says new report
25 September 2025

A new report highlights that misconceptions about the cost-benefit of innovative cancer treatments, less funding, and... Read more

Industry unites for a bold Critical Medicines Act that prioritises secure supply of medicines...
24 September 2025

Over the past decade, the European Union has faced increasing concerns regarding the availability of medicines and APIs,... Read more

A Blueprint for Action to address Obesity in the European Union

Obesity is among the most pressing public health challenges of this century and one that is posing a significant burden on Europe’s population and health systems.

It is estimated that by 2030 more than 30% of Europeans will live with obesity, with the direct and indirect costs for healthcare systems estimated to reach up to EUR 1,597 billion if no holistic action is taken.

Read the full report here.

IHI Brokerage Event 2025

Registration is now open for the IHI Brokerage Event 2025, taking place in Brussels on 4–5 November. This event offers a prime opportunity for potential applicants to network and start forming consortia ahead of IHI Call 12, scheduled for launch in early 2026. The call will invite applicants to explore new opportunities for IHI projects under the IHI Strategic Research and Innovation Agenda.

Learn more about the event here.

What we are reading

Access to novel cancer medicines in Europe: inequities across countries and their drivers
On 25 September 2025 (Science Direct)

An increasing number of cancer medicines are being developed and approved. Access to these medicines is important... Read more

Big Pharma fleeing London: UK loses ground, Europe risks domino effect
On 23 September 2025 (Il sole 24 ore)

Pharmaceutical companies are 'recalibrating' their investment geography: reducing presence in markets perceived as... Read more

Electronic patient information: Results of the e-PIL pilot from Belgium and Luxembourg hospitals...
On 23 September 2025 (Regulatory Rapporteur)

The e-PIL pilot was set up in 2018 in Belgium and Luxembourg with the objective of demonstrating the equivalence... Read more

High Level Conference – One year after the Draghi report: what has been achieved, what has...
On 16 September 2025 (European Commission)

Keynote speech by M. Draghi at the high-level EU conference on competitiveness.

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu